EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fast evolution of SOS-independent multi-drug resistance in bacteria

Le Zhang iD, Yunpeng Guan, YuenYee Cheng, Nural N Cokcetin, Amy L Bottomley, Andrew Robinson iD, Elizabeth J Harry, Antoine M van Oijen iD, Qian Peter Su iD, Dayong Jin iD

eLife · 2025

DOI: 10.7554/elife.95058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Le Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biomedical Materials and Devices (IBMD), University of Technology Sydney, Ultimo, Australia. Hauptthemen laut MEDLINE: Escherichia coli, SOS Response, Genetics, Anti-Bacterial Agents, Drug Resistance, Multiple, Bacterial. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council, Science and technology innovation commission of shen zhen, Australia China Science and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The killing mechanism of many antibiotics involves the induction of DNA damage, either directly or indirectly, which activates the SOS response. RecA, the master regulator of the SOS response, has been shown to play a central role in the evolution of resistance to fluoroquinolones, even after short-term exposure. While this paradigm is well established for DNA-damaging antibiotics, it remains unclear whether β-lactams elicit similar resistance dynamics or depend on RecA and SOS-mediated mechanisms. In this study, we observed a rapid and stable evolution of β-lactam resistance (20-fold MIC increase within 8 hr) in Escherichia coli lacking RecA after a single exposure to ampicillin. Contrary to expectation, this resistance emerged through an SOS-independent mechanism involving two distinct evolutionary forces: increased mutational supply and antibiotic-driven selection. Specifically, we found that RecA deletion impaired DNA repair and downregulated base excision repair pathways, while concurrently repressing the transcription of antioxidative defence genes. This dual impairment led to excessive accumulation of reactive oxygen species (ROS), which in turn promoted the emergence of resistance-conferring mutations. While ampicillin treatment did not alter survival, it selectively enriched for rare mutants arising in the RecA-deficient and ROS-elevated background. Collectively, our findings demonstrate that this oxidative environment, together with compromised DNA repair capacity, increases genetic instability and creates a selective landscape favouring the expansion of resistant clones. These results highlight the repair-redox axis as a key determinant of bacterial evolvability under antimicrobial stress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coliSOS Response, GeneticsAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialEvolution, MolecularRec A RecombinasesAmpicillinEscherichia coli ProteinsMicrobial Sensitivity TestsReactive Oxygen SpeciesDNA RepairMutationDNA-Binding Proteins

Stichwörter der Autor:innen

DNA repairE. coliantibiotic resistanceevolutioninfectious diseasemicrobiologymutationselection

Substanzen

Rec A RecombinasesAmpicillinAnti-Bacterial AgentsEscherichia coli ProteinsrecA protein, E coliReactive Oxygen SpeciesDNA-Binding Proteins

Autor:innen und Institutionen

  • Institute for Biomedical Materials and Devices (IBMD), University of Technology Sydney, Ultimo, Australia.
  • Australian Institute for Microbiology & Infection (AIMI), University of Technology Sydney, Ultimo, Australia.
  • School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, Australia.
  • School of Biomedical Engineering, University of Technology Sydney, Ultimo, Australia.

ORCID-Profile: Le Zhang, Andrew Robinson, Antoine M van Oijen, Qian Peter Su, Dayong Jin

Förderung

  • Australian Research Council
  • Science and technology innovation commission of shen zhen
  • Australia China Science and Research
  • National Health and Medical Research Council

Zitieren

APA

Zhang, L., Guan, Y., Cheng, Y., Cokcetin, N. N., Bottomley, A. L., Robinson, A., Harry, E. J., van Oijen, A. M., Su, Q. P., & Jin, D. (2025). Fast evolution of SOS-independent multi-drug resistance in bacteria. eLife. https://doi.org/10.7554/elife.95058

Vancouver

Zhang L, Guan Y, Cheng Y, Cokcetin NN, Bottomley AL, Robinson A, et al. Fast evolution of SOS-independent multi-drug resistance in bacteria. eLife. 2025. doi:10.7554/elife.95058

BibTeX
@article{Zhang2025,
  author = {Zhang, Le and Guan, Yunpeng and Cheng, YuenYee and Cokcetin, Nural N and Bottomley, Amy L and Robinson, Andrew and Harry, Elizabeth J and van Oijen, Antoine M and Su, Qian Peter and Jin, Dayong},
  title = {Fast evolution of SOS-independent multi-drug resistance in bacteria},
  journal = {eLife},
  year = {2025},
  doi = {10.7554/elife.95058}
}
Kostenlos starten →